Enfortumab Vedotin−Induced Cutaneous Toxic Effects and Survival in Urothelial Carcinoma

Дата публикации: 01-09-2026 00:00:00

This cohort study evaluates the association of enfortumab vedotin−induced cutaneous adverse effects with survival, including timing and morphologic mechanisms.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	High-Dose Oral Vitamin D for Toxic Effects of the Skin Associated With Chemotherapy and Radiation	0	8.17	01-09-2026
2	FLOT vs CROSS in Esophageal Adenocarcinoma	0	6.05	01-09-2026
3	ctDNA or Merkel Virus Antibodies for Surveillance of Merkel Cell Carcinoma Recurrence	0	5.43	01-09-2026
4	Surgical Outcomes of Perioperative Toripalimab in Stage III Resectable Non–Small Cell Lung Cancer	0	6.4	01-09-2026
5	Melanoma Prevention Among Children of Melanoma Survivors	0	8.06	07-10-2026
6	Consensus Guidelines for Staging and Surveillance Imaging in Cutaneous Squamous Cell Carcinoma	0	4.08	01-09-2026
7	Patient Engagement With Dermatology Notes in the Electronic Patient Portal	0	9.2	01-09-2026
8	Lumpectomy Margins and Local Recurrence in DCIS	0	8.55	01-09-2026
9	Golimumab in Treatment-Refractory Hidradenitis Suppurativa	0	7.71	01-09-2026
10	Cardiovascular Disease Risk Among Childhood and Young Adult Cancer Survivors	0	3.87	28-09-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 6.29. Источник: archderm.jamanetwork.com.